| ●Editorial | Matsuyama K | 234-5 | Full text | |
| ●Three Sequential Meetings: Consensus for Global Research Ethics and Meaningful Engagement August 25, 2025 Video and other materials September 13, 2025 Video Organized by: The Brazilian Society of Bioethics (SBB); Institute for Public Engagement (Ji4pe) Supported by: JAPERM; JAPhMed; IFAPP; Juju Barbosa Cooperation: Clinical Evaluation; Center for Bioethics Policy Study; Clinical Research Risk Management Study Group Produced by: The National Center for Child Health and Development (September 13) September 15, 2025 Organized by: The Japanese Association for Philosophical and Ethical Researches in Medicine (JAPERM) Second International Conference 2025, Open Symposium Session Produced by: The National Center for Child Health and Development |
237-80 | Full text | ||
| ●GREEN Statement | ||||
| The Statement for Global REsearch Ethics Norm and Meaningful Engagement: GREEN Statement (Original English version) ・Japanese translation ・Arabic translation |
GREEN Statement Initiative | W1-W12 | Full text | |
| ●Translations from IFAPP TODAY articles | ||||
| Global Research Ethics and Meaningful Engagement ・Original publication in English (page 4-6) | Kurihara C, Matsuyama K, Baroutsou V （Trans. by Kurihara C, Matsuyama K） |
295-8 | Full text | |
| GREEN Statement as the result of global discussions Towards the Highest Ethical Standard of Research Ethics ・Original publication in English (page 1-3) | Kurihara C, Matsuyama K, Baroutsou V, et al. （Trans. by Kurihara C, Matsuyama K, Saio T） |
299-302 | Full text | |
| Clinical Trials on Pregnant and Breastfeeding Individuals: ICH-E21 at Step 3 ・Original publication in English (page 13-4) | Kurihara C, Matsuyama K, Motoki Y （Trans. by Kurihara C, Matsuyama K, Motoki Y） |
303-4 | Full text | |
| Bridging Japan and the Global Community: Highlights from the 16th Annual Meeting of the Japanese Association of Pharmaceutical Medicine (JAPhMed) ・Original publication in English (page 4-6) | Matsuyama K （Trans. by Matsuyama K） |
305-7 | Full text | |
| ●Articles | ||||
| Revision of the proposal for the implementation of Medical Advisory Board Meetings (MABM): Process and key updates | Suzuki M, Inoue Y, Ogawa S, et al. | 309-21 | Abstract | |
| The 2024 revision of the Clinical Trial Act: Focusing on pros and cons on a company-sponsored trial in the framework of the Act | Kurihara C, Mimura M, Oi H, et al. | 323-45 | Abstract | |
| ●Forum | ||||
| White coat ceremony: A passage rite and its impact on professionalism | Kabe K, Saio T, Kurihara C, Miyaoka H | 347-56 | Abstract | |
| ●Instructions for authors［Japanese］＆［English］ | 357-65 | Full text | ||
| ●Editor’s note | Miyaoka H | 367 | Full text | |